EverSource Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $380K | Buy |
6,916
+5,479
| +381% | +$301K | 0.02% | 556 |
|
|
2025
Q1 | $102K | Buy |
1,437
+803
| +127% | +$56.8K | 0.01% | 905 |
|
|
2024
Q4 | $41.7K | Buy |
634
+531
| +516% | +$34.9K | ﹤0.01% | 1269 |
|
|
2024
Q3 | $7.24K | Buy |
103
+5
| +5% | +$351 | ﹤0.01% | 2047 |
|
|
2024
Q2 | $8.26K | Buy |
98
+9
| +10% | +$759 | ﹤0.01% | 1962 |
|
|
2024
Q1 | $7.19K | Buy |
+89
| New | +$7.19K | ﹤0.01% | 1857 |
|
|
2023
Q3 | – | Sell |
-97
| Closed | -$8.41K | – | 2523 |
|
|
2023
Q2 | $8.41K | Buy |
97
+17
| +21% | +$1.47K | ﹤0.01% | 1519 |
|
|
2023
Q1 | $7.78K | Buy |
+80
| New | +$7.78K | ﹤0.01% | 1471 |
|
|
2022
Q1 | – | Sell |
-30
| Closed | -$3K | – | 1713 |
|
|
2021
Q4 | $3K | Buy |
+30
| New | +$3K | ﹤0.01% | 1396 |
|